Cancer Research Institute Event Calendar

Subscribe

Share

2022 Sailfish Point Community Family Fun Event – Trifecta: Race Against Cancer

Join Jane and Dick Landesman for a community-building fundraiser to benefit the Cancer Research Institute. Come together with the Sailfish Point Community and help support a Future Immune to Cancer.

Whether you bike, run, walk, swim, or ride your golf cart during the day or stick around for some evening fun, 100% of the funds raised will go directly to the Cancer Research Institute to support cancer immunotherapy research.

REGISTER HERE

The History Behind the Fundraiser 

In 2008, Dr. Keith A. Landesman, a beloved son, father, and husband lost his life to cancer. Each year his parents Jane and Dick, along with their family and friends, honor his life and legacy by raising funds to support Cancer Research Institute postdoctoral fellows whose groundbreaking research expands our knowledge of cancer and its relationship to the immune system. Since 2013, the Cancer Research Institute Landesman Fund has raised more than $897,000. These funds have supported young scientists working to find immunotherapies for breast, colon, lung, and ovarian cancers, glioblastoma, leukemia, and lymphoma.

As always, you can be a part of this special cause and make a difference in the lives of those affected by cancer by registering today or giving to the Landesman Fund.

Donate to the Landesman Fund

If you wish to mail in a contribution, please make your donation payable to Cancer Research Institute and send to:

Landesman Fund
c/o Cancer Research Institute
29 Broadway, Floor 4
New York, NY 10006-3111

Current CRI-Dr. Keith Landesman Memorial Fellows

“The CRI fellowship provides me a great opportunity to explore the interaction between tumor cells and the immune system.”
—Xizhi Guo, PhD, Brigham and Women’s Hospital / Harvard Medical School, 2021-present, Investigating the Role of GATA4 in Immune Modulation During Lung Tumorigenesis

“This project will provide the rationale to design and test selective DNA-PK inhibitors in order to maximize their therapeutic effects against cancer while minimizing their side effects.”
—Yimeng Zhu, PhD, Columbia University, 2021-present, The Role of DNA-PK in DNA Repair and Ribosomal RNA Processing

Why CRI? Why Immunotherapy?

In 2021, more than 1.9 million Americans will be diagnosed with cancer, and more than 600,000 will die of cancer. Worldwide, cancer claims the lives of more than 10 million people each year. It's a global health crisis that will worsen unless we do something now to stop cancer in its tracks. By supporting the Landesman Fund, you can help us create a future immune to cancer.

Read more:

This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.